' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

HASCHKE-BECHER ELISABETH
Universitätsinstitut für Medizinisch-Chemische Labordiagnostik und medizinische Mikrobiologie

Publikationen | Forscherprofil

102 Publikationen

2019

Beiträge in Fachzeitschriften

Managing inappropriate utilization of laboratory resources.
Cadamuro, J; Ibarz, M; Cornes, M; Nybo, M; Haschke-Becher, E; von Meyer, A; Lippi, G; Simundic, AM;
Diagnosis (Berl). 2019; 6(1):5-13
Originalarbeiten (Zeitschrift)
The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.
Keppel, MH; Piecha, G; März, W; Cadamuro, J; Auer, S; Felder, TK; Mrazek, C; Oberkofler, H; Trummer, C; Grübler, MR; Schwetz, V; Verheyen, N; Pandis, M; Borzan, V; Haschke-Becher, E; Tomaschitz, A; Pilz, S;
PLoS One. 2019; 14(2):e0212973
Originalarbeiten (Zeitschrift)
Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.
Pilz, G; Wipfler, P; Otto, F; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroinflammation. 2019; 16(1):13
Originalarbeiten (Zeitschrift)

2018

Beiträge in Fachzeitschriften

Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.
Broussalis, E; Grinzinger, S; Kunz, AB; Killer-Oberpfalzer, M; Haschke-Becher, E; Hartung, HP; Kraus, J;
Acta Neurol Scand. 2018; 137(3):329-334
Originalarbeiten (Zeitschrift)
How do we use the data from pre-analytical quality indicators and how should we?
Cadamuro, J; Gaksch, M; Mrazek, C; Haschke-Becher, E; Plebani, M;
Journal of Laboratory and Precision Medicine. 2018; 4(3): 1-9.
Originalarbeiten (Zeitschrift)
Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting.
Cadamuro, J; Gaksch, M; Wiedemann, H; Lippi, G; von Meyer, A; Pertersmann, A; Auer, S; Mrazek, C; Kipman, U; Felder, TK; Oberkofler, H; Haschke-Becher, E;
Clin Biochem. 2018; 54: 85-91.
Originalarbeiten (Zeitschrift)
Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes.
Cadamuro, J; Mrazek, C; Leichtle, AB; Kipman, U; Felder, TK; Wiedemann, H; Oberkofler, H; Fiedler, GM; Haschke-Becher, E;
Biochem Med (Zagreb). 2018; 28(1): 010704
Originalarbeiten (Zeitschrift)
Dynamic reference intervals for coagulation parameters from infancy to adolescence.
Weidhofer, C; Meyer, E; Ristl, R; Wiedemann, H; Cadamuro, J; Kipman, U; Zierk, J; Male, C; Quehenberger, P; Haschke-Becher, E; Einwallner, E;
Clin Chim Acta. 2018; 482: 124-135.
Originalarbeiten (Zeitschrift)

2017

Beiträge in Fachzeitschriften

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S; Rinnerthaler, M; Bischof, J; Streubel, MK; Breitenbach-Koller, H; Geisberger, R; Aigner, E; Cadamuro, J; Richter, K; Sopjani, M; Haschke-Becher, E; Felder, TK; Breitenbach, M;
Front Oncol. 2017; 7: 111
Originalarbeiten (Zeitschrift)
Low Protein Formula: Consequences of Quantitative Effects of Pre-analytical Factors on Amino Acid Concentrations in Plasma of Healthy Infants.
Bachmann, C; Kainz, A; Haschke-Becher, E;
JIMD Rep. 2017; 32:59-67
Originalarbeiten (Zeitschrift)
To report or not to report: a proposal on how to deal with altered test results in hemolytic samples.
Cadamuro, J; Mrazek, C; Haschke-Becher, E; Sandberg, S;
Clin Chem Lab Med. 2017; 55(8): 1109-1111.
Editorials
Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia.
Cadamuro, J; Mrazek, C; Wiedemann, H; Felder, TK; Oberkofler, H; Haschke-Becher, E; Lippi, G;
Semin Thromb Hemost. 2017; 43(6): 645-648.
Letter
What´s floating on my plasma?
Cadamuro, J; Wiedemann, H; Felder, TK; Mrazek, C; Kipman, U; Hannes, O; Haschke-Becher, E
Biochem Med (Zagreb). 2017; 27(2):430-433
Fallberichte
Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers.
Felder, TK; Ring-Dimitriou, S; Auer, S; Soyal, SM; Kedenko, L; Rinnerthaler, M; Cadamuro, J; Haschke-Becher, E; Aigner, E; Paulweber, B; Patsch, W;
J Sci Med Sport. 2017; 20(7):-705
Originalarbeiten (Zeitschrift)
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
Feldman, A; Eder, SK; Felder, TK; Kedenko, L; Paulweber, B; Stadlmayr, A; Huber-Schönauer, U; Niederseer, D; Stickel, F; Auer, S; Haschke-Becher, E; Patsch, W; Datz, C; Aigner, E;
Am J Gastroenterol. 2017; 112(1):102-110
Originalarbeiten (Zeitschrift)
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
Harrer, A; Pilz, G; Oppermann, K; Sageder, M; Afazel, S; Haschke-Becher, E; Rispens, T; de Vries, A; McCoy, M; Stevanovic, V; Hitzl, W; Trinka, E; Kraus, J; Sellner, J; Wipfler, P;
Clin Immunol. 2017; 176: 87-93.
Originalarbeiten (Zeitschrift)
The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts.
Mrazek, C; Simundic, AM; Wiedemann, H; Krahmer, F; Felder, TK; Kipman, U; Hoppe, U; Haschke-Becher, E; Cadamuro, J;
Clin Chem Lab Med. 2017; 55(8):1129-1134
Originalarbeiten (Zeitschrift)
Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome.
Pilz, G; Wipfler, P; Schwarte, O; Golaszewski, S; McCoy, M; Haschke-Becher, E; Hartung, HP; Kraus, J;
J Neurol. 2017; 264(4): 799-801.
Letter
Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner, C; Lichtenauer, M; Wernly, B; Paar, V; Pistulli, R; Rohm, I; Jung, C; Figulla, HR; Yilmaz, A; Cadamuro, J; Haschke-Becher, E; Pernow, J; Schulze, PC; Hoppe, UC; Kretzschmar, D;
Eur J Clin Invest. 2017; 47(9): 638-648.
Originalarbeiten (Zeitschrift)
Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction.
Schernthaner, C; Paar, V; Wernly, B; Pistulli, R; Rohm, I; Jung, C; Figulla, HR; Yilmaz, A; Cadamuro, J; Haschke-Becher, E; Schulze, PC; Hoppe, UC; Lichtenauer, M; Kretzschmar, D;
Medicine (Baltimore). 2017; 96(44): e8396
Originalarbeiten (Zeitschrift)
Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
Stechemesser, L; Eder, SK; Wagner, A; Patsch, W; Feldman, A; Strasser, M; Auer, S; Niederseer, D; Huber-Schönauer, U; Paulweber, B; Zandanell, S; Ruhaltinger, S; Weghuber, D; Haschke-Becher, E; Grabmer, C; Rohde, E; Datz, C; Felder, TK; Aigner, E;
Mol Metab. 2017; 6(1):38-47
Originalarbeiten (Zeitschrift)
Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N; Kremser, I; Auer, S; Hoermann, G; Greil, R; Haschke-Becher, E; Esterbauer, H; Kenner, L; Oberkofler, H;
J Acquir Immune Defic Syndr. 2017; 75(1):e13-e20
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab
Harrer, A; Frommrich, M; Moser, T; Afazel, S; Haschke-Becher, E; Wipfler, P; Sellner, J
MULT SCLER J. 2017; 23: 337-338.
Abstracts (Zeitschrift)

2016

Beiträge in Fachzeitschriften

Reply to: Cadamuro et al. In-vitro hemolysis and its financial impact using different blood collection systems
Cadamuro, J; Fiedler, GM; Mrazek, C; Felder, TK; Oberkofler, H; Kipman, U; Haschke-Becher, E; Wiedemann, H
LABORATORIUMSMEDIZIN. 2016; 40(1): 59-61.
Author reply
In-vitro hemolysis and its financial impact using different blood collection systems
Cadamuro, J; Fiedler, GM; Mrazek, C; Felder, TK; Oberkofler, H; Kipman, U; Haschke-Becher, E; Wiedemann, H
LABORATORIUMSMEDIZIN. 2016; 40(1): 49-55.
Originalarbeiten (Zeitschrift)
Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training.
Cadamuro, J; von Meyer, A; Wiedemann, H; Felder, TK; Moser, F; Kipman, U; Haschke-Becher, E; Mrazek, C; Simundic, AM;
Clin Chem Lab Med. 2016; 54(12): 1987-1992.
Originalarbeiten (Zeitschrift)
Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months
Haschke-Becher, E; Kainz, A; Bachmann, C
J INHERIT METAB DIS. 2016; 39(1): 25-37.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

SPECIFIC CIRCULATING PHOSPHOLIPIDS, ACYLCARNITINES, AMINO ACIDS AND BIOGENIC AMINES ARE AEROBIC EXERCISE MARKERS
Felder, T; Ring-Dimitriou, S; Auer, S; Soyal, S; Kedenko, L; Rinnerthaler, M; Cadamuro, J; Haschke-Becher, E; Aigner, E; Paulweber, B; Patsch, W
ATHEROSCLEROSIS. 2016; 252: E121-E121.
Abstracts (Zeitschrift)

2015

Beiträge in Fachzeitschriften

Relevance of EDTA carryover during blood collection.
Cadamuro, J; Felder, TK; Oberkofler, H; Mrazek, C; Wiedemann, H; Haschke-Becher, E;
Clin Chem Lab Med. 2015; 53(8):1271-1278
Originalarbeiten (Zeitschrift)
The economic burden of hemolysis.
Cadamuro, J; Wiedemann, H; Mrazek, C; Felder, TK; Oberkofler, H; Fiedler, GM; Haschke-Becher, E;
Clin Chem Lab Med. 2015; 53(11): e285-e288.
Letter
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Harrer, A; Pilz, G; Wipfler, P; Oppermann, K; Sellner, J; Hitzl, W; Haschke-Becher, E; Afazel, S; Rispens, T; van der Kleij, D; Trinka, E; Kraus, J;
Clin Exp Immunol. 2015; 180(3):383-392
Originalarbeiten (Zeitschrift)
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Harrer, A; Wipfler, P; Pilz, G; Oppermann, K; Haschke-Becher, E; Afazel, S; Kraus, J; Trinka, E; Sellner, J;
Int J Mol Sci. 2015; 16(9): 21832-21845.
Originalarbeiten (Zeitschrift)
Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations.
Ponschab, M; Schöchl, H; Gabriel, C; Süssner, S; Cadamuro, J; Haschke-Becher, E; Gratz, J; Zipperle, J; Redl, H; Schlimp, CJ;
Anaesthesia. 2015; 70(5): 528-536.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

SOLUBLE P-SELECTIN PREDICTS CARDIOVASCULAR EVENTS IN END STAGE RENAL DISEASE
Sailer, T; Haschke-Becher, E; Pabinger, I; Ay, C; Oberbauer, R
NEPHROL DIAL TRANSPL. 2015; 30:
Abstracts (Zeitschrift)

2014

Beiträge in Fachzeitschriften

Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six-year follow-up of a prospective randomized double-blind monocenter study on low-dose DHA supplements.
Bergmann, RL; Bergmann, KE; Richter, R; Haschke-Becher, E; Henrich, W; Dudenhausen, JW
J Perinat Med. 2014; 40(6):677-684
Originalarbeiten (Zeitschrift)
TaqManR proximity ligation technology for the detection of heterodimeric adhesion receptors on lymphocytes.
Gehwolf, R; Band, E; Trost, A; Iglseder, B; Trinka, E; Haschke-Becher, E; Kraus, J; Harrer, A;
J Immunol Methods. 2014; 404:81-86
Originalarbeiten (Zeitschrift)
A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with reduced therapy efficiency under natalizumab
Oppermann, K; Harrer, A; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Sellner, J; Deisenhammer, F; Trinka, E; Kraus, J
LABORATORIUMSMEDIZIN. 2014; 38(1): 17-23.
Originalarbeiten (Zeitschrift)
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Province, MA; Goetz, MP; Brauch, H; Flockhart, DA; Hebert, JM; Whaley, R; Suman, VJ; Schroth, W; Winter, S; Zembutsu, H; Mushiroda, T; Newman, WG; Lee, MT; Ambrosone, CB; Beckmann, MW; Choi, JY; Dieudonné, AS; Fasching, PA; Ferraldeschi, R; Gong, L; Haschke-Becher, E; Howell, A; Jordan, LB; Hamann, U; Kiyotani, K; Krippl, P; Lambrechts, D; Latif, A; Langsenlehner, U; Lorizio, W; Neven, P; Nguyen, AT; Park, BW; Purdie, CA; Quinlan, P; Renner, W; Schmidt, M; Schwab, M; Shin, JG; Stingl, JC; Wegman, P; Wingren, S; Wu, AH; Ziv, E; Zirpoli, G; Thompson, AM; Jordan, VC; Nakamura, Y; Altman, RB; Ames, MM; Weinshilboum, RM; Eichelbaum, M; Ingle, JN; Klein, TE;
Clin Pharmacol Ther. 2014; 95(2):216-227
Originalarbeiten (Zeitschrift)
Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor, N; Haschke-Becher, E; Greil, R; Strasser, M; Oberkofler, H;
Antivir Ther. 2014; 19(5): 449-454.
Originalarbeiten (Zeitschrift)
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Wipfler, P; Harrer, A; Pilz, G; Oppermann, K; Afazel, S; Haschke-Becher, E; Sellner, J; Trinka, E; Kraus, J;
Acta Neurol Scand. 2014; 129(3):e12-e15
Originalarbeiten (Zeitschrift)

2013

Beiträge in Fachzeitschriften

Feeding patterns during the first 2 years and health outcome.
Haschke, F; Haiden, N; Detzel, P; Yarnoff, B; Allaire, B; Haschke-Becher, E
Ann Nutr Metab. 2013; 62 Suppl 3:16-25
Originalarbeiten (Zeitschrift)
Evaluation of growth and early infant feeding: a challenge for scientists, industry and regulatory bodies.
Haschke, F; Steenhout, P; Grathwohl, D; Haschke-Becher, E
World Rev Nutr Diet. 2013; 106:33-38
Übersichtsarbeiten
A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed, M; Burnside, G; Eriksson, N; Jorgensen, AL; Toh, CH; Nicholson, T; Kesteven, P; Christersson, C; Wahlström, B; Stafberg, C; Zhang, JE; Leathart, JB; Kohnke, H; Maitland-van der Zee, AH; Williamson, PR; Daly, AK; Avery, P; Kamali, F; Wadelius, M;
N Engl J Med. 2013; 369(24): 2294-2303.
Originalarbeiten (Zeitschrift)
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Sellner, J; Koczi, W; Harrer, A; Oppermann, K; Obregon-Castrillo, E; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
Clin Exp Immunol. 2013; 173(3):381-389
Originalarbeiten (Zeitschrift)
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef, TI; Ragia, G; de Boer, A; Barallon, R; Kolovou, G; Kolovou, V; Konstantinides, S; Le Cessie, S; Maltezos, E; van der Meer, FJ; Redekop, WK; Remkes, M; Rosendaal, FR; van Schie, RM; Tavridou, A; Tziakas, D; Wadelius, M; Manolopoulos, VG; Maitland-van der Zee, AH;
N Engl J Med. 2013; 369(24): 2304-2312.
Originalarbeiten (Zeitschrift)
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.
Verhoef, TI; Redekop, WK; Veenstra, DL; Thariani, R; Beltman, PA; van Schie, RM; de Boer, A; Maitland-van der Zee, AH;
Pharmacogenomics. 2013; 14(8): 869-883.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Shift in the CD4+/CD8+ratio of cerebrospinal fluid T cells independent from free or cell-bound natalizumab
Harrer, A; Oppermann, K; Pizl, G; Wipfler, P; Sellner, J; Hitzl, W; Haschke-Becher, E; Afazel, S; Rispens, T; van der Kleij, D; Trinka, E; Kraus, J
MULT SCLER J. 2013; 19(11): 451-452.
Abstracts (Zeitschrift)
Flow-cytometry and the detection of natalizumab-neutralizing antibodies in multiple sclerosis
Oppermann, K; Harrer, A; Pilz, G; Wipfler, P; Holl, B; Deisenhammer, F; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
MULT SCLER J. 2013; 19(11): 500-501.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

Pharmakogenetik
Haschke-Becher, E
In: Dörner, K. (Hrsg.) editors(s). Taschenlehrbuch Klinische Chemie und Hämatologie. (20.5): Thieme; p. 572-574.

2012

Beiträge in Fachzeitschriften

Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis, E; Hutterer, M; Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Haschke-Becher, E; Golaszewski, S; Schönauer, U; Weis, S; Killer-Oberpfalzer, M; Mc Coy, M; Trinka, E; Kraus, J;
Acta Neurol Scand. 2012; 126(3):e11-e16
Fallberichte
Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis
Harrer, A; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, L; Trinka, E; Kraus, J
LABORATORIUMSMEDIZIN. 2012; 36(6): 377-382.
Originalarbeiten (Zeitschrift)
Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.
Harrer, A; Pilz, G; Einhaeupl, M; Oppermann, K; Hitzl, W; Wipfler, P; Sellner, J; Golaszewski, S; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
PLoS One. 2012; 7(2):e31784
Originalarbeiten (Zeitschrift)
Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we?
Huber-Wechselberger, AE; Niedetzky, P; Aigner, I; Haschke-Becher, E;
Wien Med Wochenschr. 2012; 162(11-12):252-261
Übersichtsarbeiten
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.
Pilz, G; Harrer, A; Oppermann, K; Wipfler, P; Golaszewski, S; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
Mult Scler. 2012; 18(4):506-509
Originalarbeiten (Zeitschrift)
An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol.
van Schie, RM; Babajeff, AM; Schalekamp, T; Wessels, JA; le Cessie, S; de Boer, A; van der Meer, FJ; van Meegen, E; Verhoef, TI; Rosendaal, FR; Maitland-van der Zee, AH;
J Thromb Haemost. 2012; 10(5):767-772
Originalarbeiten (Zeitschrift)
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.
Verhoef, TI; Redekop, WK; Buikema, MM; Schalekamp, T; Van Der Meer, FJ; Le Cessie, S; Wessels, JA; Van Schie, RM; De Boer, A; Teichert, M; Visser, LE; Maitland-Van Der Zee, AH;
J Thromb Haemost. 2012; 10(4): 606-614.
Originalarbeiten (Zeitschrift)
Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users.
Verhoef, TI; Redekop, WK; Hegazy, H; de Boer, A; Maitland-van der Zee, AH;
J Thromb Haemost. 2012; 10(12): 2610-2612.
Letter
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs.
Verhoef, TI; Redekop, WK; van Schie, RM; Bayat, S; Daly, AK; Geitona, M; Haschke-Becher, E; Hughes, DA; Kamali, F; Levin, LÅ; Manolopoulos, VG; Pirmohamed, M; Siebert, U; Stingl, JC; Wadelius, M; de Boer, A; Maitland-van der Zee, AH;
Pharmacogenomics. 2012; 13(12): 1405-1417.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Natalizumab Treatment Effects Sustained Decrease in Serum Levels of Fibronectin and Soluble Adhesion Molecules sVCAM-1 and sICAM-3
Kraus, J; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A
NEUROLOGY. 2012; 78:
Abstracts (Zeitschrift)
Serum Levels of Soluble Adhesion Molecules Remain Stable during Short- and Long-Term Interferon-beta-1b Treatment
Kraus, J; Zaunrieth, R; Obregon-Castrillo, E; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Golaszewski, S; Hitzl, W; Trinka, E; Harrer, A
NEUROLOGY. 2012; 78:
Abstracts (Zeitschrift)

2011

Beiträge in Fachzeitschriften

A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery, PJ; Jorgensen, A; Hamberg, AK; Wadelius, M; Pirmohamed, M; Kamali, F;
Clin Pharmacol Ther. 2011; 90(5): 701-706.
Originalarbeiten (Zeitschrift)
The case: hemolysis and acute renal failure. Babesiosis.
Blum, S; Gattringer, R; Haschke, E; Walochnik, J; Tschurtschenthaler, G; Lang, F; Oberbauer, R;
Kidney Int. 2011; 80(6): 681-683.
Editorials
Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
Harrer, A; Wipfler, P; Einhaeupl, M; Pilz, G; Oppermann, K; Hitzl, W; Afazel, S; Haschke-Becher, E; Strasser, P; Trinka, E; Kraus, J;
J Neuroimmunol. 2011; 234(1-2):148-154
Originalarbeiten (Zeitschrift)
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.
Kohlmann, A; Klein, HU; Weissmann, S; Bresolin, S; Chaplin, T; Cuppens, H; Haschke-Becher, E; Garicochea, B; Grossmann, V; Hanczaruk, B; Hebestreit, K; Gabriel, C; Iacobucci, I; Jansen, JH; te Kronnie, G; van de Locht, L; Martinelli, G; McGowan, K; Schweiger, MR; Timmermann, B; Vandenberghe, P; Young, BD; Dugas, M; Haferlach, T;
Leukemia. 2011; 25(12): 1840-1848.
Originalarbeiten (Zeitschrift)
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
Parmar, S; Stingl, JC; Huber-Wechselberger, A; Kainz, A; Renner, W; Langsenlehner, U; Krippl, P; Brockmöller, J; Haschke-Becher, E;
Breast Cancer Res. 2011; 13(3): R57
Originalarbeiten (Zeitschrift)
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.
van Schie, RM; Wessels, JA; le Cessie, S; de Boer, A; Schalekamp, T; van der Meer, FJ; Verhoef, TI; van Meegen, E; Rosendaal, FR; Maitland-van der Zee, AH;
Eur Heart J. 2011; 32(15): 1909-1917.
Originalarbeiten (Zeitschrift)
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
Wipfler, P; Oppermann, K; Pilz, G; Afazel, S; Haschke-Becher, E; Harrer, A; Huemer, M; Kunz, A; Golaszewski, S; Staffen, W; Ladurner, G; Kraus, J;
Mult Scler. 2011; 17(1):16-23
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Natalizumab binding to peripheral blood mononuclear cells analysed by flow cytometry can be used for monitoring treatment response in patients with multiple sclerosis
Harrer, A; Pilz, G; Einhaeupl, M; Oppermann, K; Wipfler, P; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
J NEUROL. 2011; 258: 13-14.
Abstracts (Zeitschrift)
A NOVEL MARKER PANEL FOR BRAIN TUMOURS?
Jaksch, H; Strasser, P; Krenn, Y; Golaszewski, S; Kleindienst, W; Hutterer, M; Haschke-Becher, E; Weis, S; Trinka, E; Eckl, P; Bresgen, N
EUR J NEUROL. 2011; 18: 603-603.
Abstracts (Zeitschrift)
Anti-Inflammatory Effects of Copaxone on the Level of Adhesion Molecule Expression Patterns during Short- and Long-Term Treatment
Kraus, J; Oppermann, K; Harrer, A; Koczi, W; Duerr, EM; Wipfler, P; Pilz, G; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E
NEUROLOGY. 2011; 76(9): A384-A384.
Abstracts (Zeitschrift)
Flow Cytometry of Natalizumab Binding to Immune Cells and Its Potential Use for Monitoring Disease Activity and Treatment Response in Patients with Multiple Sclerosis
Kraus, J; Pilz, G; Einhaeupl, M; Oppermann, K; Wipfler, P; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A
NEUROLOGY. 2011; 76(9): A135-A136.
Abstracts (Zeitschrift)
Copaxone treatment shows anti-inflammatory effects on the level of adhesion molecule expression on peripheral blood mononuclear cells during short- and long-term therapy
Oppermann, K; Harrer, A; Koczi, W; Duerr, E; Wipfler, P; Pilz, G; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
J NEUROL. 2011; 258: 206-206.
Abstracts (Zeitschrift)
USEFULNES OF URINARY BIOMARKER NGAL IN THE MANAGEMENT OF RENAL REPLACEMENT THERAPY (RRT, HEMOFILTRATION)
Stanger, O; Aigner, I; Mitterwallner, S; Haschke-Becher, E
CLIN CHEM LAB MED. 2011; 49: S362-S362.
Abstracts (Zeitschrift)

2010

Beiträge in Fachzeitschriften

First detection of the Anaplasma phagocytophilum groEL-A genotype in man.
Haschke-Becher, E; Bernauer, R; Walleczek, AM; Apfalter, P; Afazel-Saeedi, S; Kraus, J; Ladurner, G; Strasser, P;
J INFECTION. 2010; 60(4): 300-305.
Fallberichte
Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.
Haschke-Becher, E; Kirchheiner, J; Trummer, O; Grünbacher, G; Kainz, A; Boehm, BO; März, W; Renner, W;
Pharmacogenomics. 2010; 11(10): 1359-1365.
Originalarbeiten (Zeitschrift)
Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.
Stingl, JC; Parmar, S; Huber-Wechselberger, A; Kainz, A; Renner, W; Seeringer, A; Brockmöller, J; Langsenlehner, U; Krippl, P; Haschke-Becher, E;
Curr Med Res Opin. 2010; 26(11):2535-2542
Originalarbeiten (Zeitschrift)
Novel mutation at codon 110 of the human APOE gene: impact on genotyping with fluorescent hybridization probes
Strasser, P; Iglseder, B; Ladurner, G; Haschke-Becher, E
CLIN CHEM LAB MED. 2010; 48(12): 1835-1836.
Letter
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives.
Verhoef, TI; Redekop, WK; Darba, J; Geitona, M; Hughes, DA; Siebert, U; de Boer, A; Maitland-van der Zee, AH; Barallon, R; Briz, M; Daly, A; Haschke-Becher, E; Kamali, F; Kirchheiner, J; Manolopoulos, VG; Pirmohamed, M; Rosendaal, FR; van Schie, RM; Wadelius, M;
Pharmacogenomics. 2010; 11(7): 989-1002.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Continuous Down-Regulation of VLA-4 and Accumulation of Natalizumab at the VLA-4 Receptor: Potential Molecular Basis of Enhanced Treatment Efficacy and Occurrence of Opportunistic Infections
Kraus, J; Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Afazel, S; Haschke-Becher, E; Kunz, AB; Golaszewski, SM; Staffen, W; Ladurner, G
NEUROLOGY. 2010; 74(9): A416-A416.
Abstracts (Zeitschrift)
Short- and long-term decrease of soluble adhesion molecules (sICAM-1,-2,-3 and sVCAM-1) during natalizumab treatment
Oppermann, K; Pilz, G; Wipfler, P; Harrer, A; Sulzer, C; Afazel, S; Haschke-Becher, E; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S220-S220.
Abstracts (Zeitschrift)
Expression levels of cell surface bound interferon-receptor remain stable during short- and long-term interferon beta-1b treatment
Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Duerr, EM; Koczi, W; Sulzer, C; Afazel, S; Haschke-Becher, E; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S219-S219.
Abstracts (Zeitschrift)
Accumulation of natalizumab at the VLA-4 receptor as a potential molecular basis of enhanced treatment efficacy and occurrence of opportunistic infections
Wipfler, P; Oppermann, K; Pilz, G; Harrer, A; Haschke-Becher, E; Kunz, A; Golaszewski, S; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S8-S8.
Abstracts (Zeitschrift)

2009

Beiträge in Fachzeitschriften

Clinical decision rules for the use of liquor diagnostics in hospitalized neurology patients reduced costs without affecting clinical outcomes.
Haschke-Becher, E; Totzke, U; Afazel, S; Johansson, T; Schwarz, M; Ladurner, G; Wild, C;
INT J TECHNOL ASSESS. 2009; 25(2): 208-213.
Originalarbeiten (Zeitschrift)
Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations.
Stanger, O; Fowler, B; Piertzik, K; Huemer, M; Haschke-Becher, E; Semmler, A; Lorenzl, S; Linnebank, M;
Expert Rev Neurother. 2009; 9(9): 1393-1412.
Übersichtsarbeiten
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
van Schie, RM; Wadelius, MI; Kamali, F; Daly, AK; Manolopoulos, VG; de Boer, A; Barallon, R; Verhoef, TI; Kirchheiner, J; Haschke-Becher, E; Briz, M; Rosendaal, FR; Redekop, WK; Pirmohamed, M; Maitland van der Zee, AH;
PHARMACOGENOMICS. 2009; 10(10): 1687-1695.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Short-term decrease of soluble adhesion molecules during natalizumab treatment
Oppermann, K; Pilz, G; Wipfler, P; Sulzer, C; Afazel, S; Haschke-Becher, E; Kunz, A; Golaszewski, S; Ladurner, G; Kraus, J
MULT SCLER. 2009; 15(9): S133-S133.
Abstracts (Zeitschrift)
Natalizumab Treatment Leads to Changes in Adhesion Molecule Expression
Wipfler, P; Pilz, G; Oppermann, K; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G; Kraus, J
NEUROLOGY. 2009; 72(11): A37-A38.
Abstracts (Zeitschrift)
Long-term effect of natalizumab on cell surface bound adhesion molecules expression
Wipfler, P; Pilz, G; Oppermann, K; Afazel, S; Huemer, M; Haschke-Becher, E; Staffen, W; Ladurner, G; Kraus, J
MULT SCLER. 2009; 15(9): S195-S196.
Abstracts (Zeitschrift)

2008

Beiträge in Fachzeitschriften

Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants.
Bergmann, RL; Haschke-Becher, E; Klassen-Wigger, P; Bergmann, KE; Richter, R; Dudenhausen, JW; Grathwohl, D; Haschke, F;
ANN NUTR METAB. 2008; 52(2): 157-166.
Originalarbeiten (Zeitschrift)
Urinary D-Lactate Excretion in Infants Receiving Lactobacillus johnsonii with Formula
Haschke-Becher, E; Brunser, O; Cruchet, S; Gotteland, M; Haschke, F; Bachmann, C
ANN NUTR METAB. 2008; 53(3-4): 240-244.
Originalarbeiten (Zeitschrift)
A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome.
Haschke-Becher, E; Vockenhuber, M; Niedetzky, P; Totzke, U; Gabriel, C;
CLIN CHEM LAB MED. 2008; 46(1): 85-88.
Originalarbeiten (Zeitschrift)
Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study.
Kohlmann, A; Haschke-Becher, E; Wimmer, B; Huber-Wechselberger, A; Meyer-Monard, S; Huxol, H; Siegler, U; Rossier, M; Matthes, T; Rebsamen, M; Chiappe, A; Diemand, A; Rauhut, S; Johnson, A; Liu, WM; Williams, PM; Wieczorek, L; Haferlach, T;
CLIN CHEM. 2008; 54(10): 1705-1715.
Originalarbeiten (Zeitschrift)
Safety and efficacy of a new extensively hydrolyzed formula for infants with cow"s milk protein allergy.
Niggemann, B; von Berg, A; Bollrath, C; Berdel, D; Schauer, U; Rieger, C; Haschke-Becher, E; Wahn, U;
Pediatr Allergy Immunol. 2008; 19(4):348-354
Originalarbeiten (Zeitschrift)
Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas.
Velaphi, SC; Cooper, PA; Bolton, KD; Mokhachane, M; Mphahlele, RM; Beckh-Arnold, E; Monaheng, L; Haschke-Becher, E;
Nutrition. 2008; 24(3):203-211
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Changes in adhesion molecule expression induced by natalizumab treatment in multiple sclerosis
Kraus, J; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G
MULT SCLER. 2008; 14: S133-S133.
Abstracts (Zeitschrift)
Influence of natalizumab treatment on a panel of cell surface bound adhesion molecules
Wipfler, P; Pilz, G; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G; Kraus, J
J NEUROL. 2008; 255: 211-211.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

Einfluss einer Therapie der Multiplen Sklerose mit Natalizumab auf die Expression von zellgebundenen Adhäsionsmolekülen
Kraus, J; Wipfler, P; Pilz, G; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G
Akt Neurol. 2008. 35 - P584:

2007

Beiträge in Fachzeitschriften

Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?
Bergmann, RL; Bergmann, KE; Haschke-Becher, E; Richter, R; Dudenhausen, JW; Barclay, D; Haschke, F
J PERINAT MED. 2007; 35(4): 295-300.
Originalarbeiten (Zeitschrift)

2006

Beiträge in Fachzeitschriften

Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants.
Brunser, O; Figueroa, G; Gotteland, M; Haschke-Becher, E; Magliola, C; Rochat, F; Cruchet, S; Palframan, R; Gibson, G; Chauffard, F; Haschke, F;
Asia Pac J Clin Nutr. 2006; 15(3):368-376
Originalarbeiten (Zeitschrift)

2002

Beiträge in Fachzeitschriften

Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months.
Räihä, NC; Fazzolari-Nesci, A; Cajozzo, C; Puccio, G; Monestier, A; Moro, G; Minoli, I; Haschke-Becher, E; Bachmann, C; Van"t Hof, M; Carrié Fässler, AL; Haschke, F;
J Pediatr Gastroenterol Nutr. 2002; 35(3): 275-281.
Originalarbeiten (Zeitschrift)

2000

Beiträge in Fachzeitschriften

Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit.
Haschke-Becher, E; Baumgartner, M; Bachmann, C;
Clin Chim Acta. 2000; 298(1-2): 99-109.
Originalarbeiten (Zeitschrift)

1994

Beiträge in Fachzeitschriften

"Salt-split" test on normal, non-sun-exposed skin of patients with autoimmune subepidermal bullous diseases.
Pohla-Gubo, G; Becher, E; Romani, N; Fritsch, P; Hintner, H;
Dermatology. 1994; 189 Suppl 1: 123
Originalarbeiten (Zeitschrift)